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Primordial dwarfism (PD) is characterized by global
growth failure, both during embryogenesis and
postnatally. Loss-of-function germline mutations
in La ribonucleoprotein domain family, member 7
(LAPR7) have recently been linked to PD. Paradoxi-
cally, LARP7 deficiency was previously assumed
to be associated with increased cell growth and
proliferation via activation of positive transcription
elongation factor b (P-TEFb). Here, we show that
Larp7 deficiency likely does not significantly increase
P-TEFb activity. We further discover that Larp7
knockdown does not affect pluripotency but instead
primes embryonic stem cells (ESCs) for differentia-
tion via downregulation of Lin28, a positive regulator
of organismal growth. Mechanistically, we show that
Larp7 interacts with a poly(A) polymerase Star-PAP
to maintain Lin28 mRNA stability. We propose that
proper regulation of Lin28 and PTEFb is essential
for embryonic cells to achieve a sufficient number
of cell divisions prior to differentiation and ultimately
to maintain proper organismal size.
INTRODUCTION
Primordial dwarfism (PD) is a group of single-gene human disor-
ders characterized by extreme global growth failure in utero and
postnatally. PD differs from other forms of dwarfism in that most
body parts in affected individuals are smaller but with otherwise
normal anthropometric proportions. In addition, most individuals
also have microcephaly, a reduction in head size proportional
to or smaller than their body size. Although PD has been consid-
ered to be a recessive inheritable trait for over a century, culprit
genes have only recently been identified. Interestingly, most PD
genes function in DNA replication and damage response path-
ways under normal physiological conditions. Of note, mutations
in U4atac small nuclear RNA (snRNA), a component of the minor
spliceosome, have also been linked to PD. Nevertheless, howdefects in these genes lead to PD remains poorly understood
(Klingseisen and Jackson, 2011).
Loss-of-function germline mutations in La ribonucleoprotein
domain family, member 7 (LAPR7) have recently been linked to
PD (Alazami et al., 2012; Najmabadi et al., 2011). LARP7 protein
was initially identified as a constituent binding partner of 7SK
snRNA in 7SK ribonucleoprotein complex (7SK RNP) (He et al.,
2008; Krueger et al., 2008; Markert et al., 2008). The only known
function of 7SK RNP is to recruit RNA-binding proteins HEXIM1
or HEXIM2 and subsequently sequester positive transcription
elongation factor b (P-TEFb) (Michels et al., 2004; Nguyen
et al., 2001; Yang et al., 2001; Yik et al., 2003). P-TEFb,
composed of CDK9 catalytic subunit and cyclin T regulatory
subunit, is a key factor to release RNA polymerase II from pro-
moter-proximal pausing to productive elongation phase in
most genes (Peterlin and Price, 2006; Zhou et al., 2012). Thus,
it is generally agreed that upregulation of P-TEFb activity acti-
vates gene transcription globally (Zhou and Yik, 2006). Indeed,
prolonged overexpression of P-TEFb subunit leads to cellular
growth in nondividing cells due to increased biomass synthesis
(Cherrier et al., 2013; Sano et al., 2002; Sano and Schneider,
2004). P-TEFb activity is also frequently increased in cancer cells
and required for cell proliferation (Smith et al., 2011; Wang and
Fischer, 2008). Most cellular P-TEFb is held in an inactive state
by 7SK RNP (Byers et al., 2005; Li et al., 2005, 2007). LARP7
appears to maintain the stability of 7SK RNA in cells, although
not being required to inhibit P-TEFb in vitro. Knockdown of
LARP7 appears to free P-TEFb from 7SK RNP and is assumed
to increase the cellular activity of P-TEFb (He et al., 2008;
Krueger et al., 2008; Markert et al., 2008). Thus, it is paradoxical
that loss of LARP7 function leads to global growth failure (Ala-
zami et al., 2012).
Embryonic stem cells (ESCs) are self-renewing, pluripotent
cells, capable of generating all cell types in three germ layers.
ESCs can be propagated indefinitely in vitro under optimal con-
ditions (Evans, 2011; Yu and Thomson, 2008). Interestingly,
recent studies have demonstrated that in serum, mouse
ESCs fluctuate between a naive state (resembling inner cell
mass in blastocyst) and a primed state (a more differentiated
state resembling developmentally more advanced epiblast)
(Ying et al., 2008). Self-renewal and pluripotency in both statesCell Reports 7, 735–746, May 8, 2014 ª2014 The Authors 735
Figure 1. Regulation of P-TEFb by Larp7
in ESCs
(A) Knockdown of Larp7 in ESCs. Two shRNAs
targeting Larp7 (L7-1 and L7-2) were individually
transfected into ESCs and selected by puromycin
for 5 days. mRNA (upper panel) and protein levels
(lower panel) were determined by RT-PCR and
western blot analysis, respectively. ns denotes a
minor nonspecific band detected by anti-Larp7
antibody.
(B) Expression of P-TEFb subunits analyzed by
western blotting when Larp7 was knocked down
for 3 days.
(C) Expression of P-TEFb subunits analyzed by
western blotting when Larp7 was knocked down
for 5 days.
(D) Glycerol gradient analyses of P-TEFb dy-
namics. Extracts from cells treated with tran-
scriptional inhibitors, including 5,6-dichloro-1-
b-D-ribofuranosylbenzimidazole (DRB, 50 mM)
and flavopiridol (Flavo, 500 nM), UV light (40 J/M2),
or shRNA knockdown, were separated by linear
glycerol gradient. Fractions were analyzed by
western blotting using anti-Cdk9 antibody.
(E) RNA pol II CTD Ser-2 phosphorylation status
before and after knockdown of Larp7. DRB and
Flavo are well established inhibitors of P-TEFb and
can efficiently eliminate Ser-2 phosphorylation.
(F) RNA blot analyses of 7SK, U2, and U6 snRNA
before and after knockdown of Larp7 for 5 days.
(G) Quantitative PCR (qPCR) analysis of Cdk9
mRNA after Larp7 was knocked down for 5 days.aremaintained by the same set of core pluripotency transcription
factors, such as Oct4 and Nanog, while key differences exist.
ESCs in the primed state exhibit flattened cell morphology, ex-
press lineage-specific transcripts, such as Fgf5 and Blimp1,
have low clonogenicity, and are unable to contribute to blasto-
cyst chimeras (De Los Angeles et al., 2012; Nichols and Smith,
2009, 2012). Of note, it is a common observation that ESCs
cultured in serum exhibit spontaneous differentiation, likely
because those in the primed state are prone to differentiation.
At the molecular level, precocious transcription of lineage-
affiliated genes in naive state is restrained by RNA polymerase
II promoter-proximal pausing. In the primed state, releasing
RNA polymerase II into productive transcriptional elongation
at these genes is a widespread mechanism of upregulation of
gene expression (Marks et al., 2012). However, it is not known
if P-TEFb is involved. The understanding of the molecular
circuitries that regulate the naive and primed states of ESCs is
still at an early stage (De Los Angeles et al., 2012; Nichols and
Smith, 2012).
ESCs offer a unique and excellent system to model human
diseases in vitro because of their abilities to generate many
cell types (Merkle and Eggan, 2013; Robinton and Daley, 2012;
Tiscornia et al., 2011). Interestingly, it has been speculated that
defects in PD gene functions may reduce the number of embry-
onic cells very early in development to account for the smaller
size of embryos observed in utero (Klingseisen and Jackson,
2011). However, it is not known if any aspects of ESCs are
affected in individuals with PD. Because mutations in LARP7
are of germline, we reasoned that ESCs would be an ideal sys-736 Cell Reports 7, 735–746, May 8, 2014 ª2014 The Authorstem to investigate the underlying mechanisms for this develop-
mental disorder.
Here, we show that loss of Larp7 primes ESCs for differentia-
tion via dysregulation of Lin28, a factor recently emerged as an
important positive regulator of mammalian body size. Mechanis-
tically, we uncover that Larp7 interacts with a poly(A) polymerase
Star-PAP to maintain Lin28 mRNA stability. We propose that
proper regulation of Lin28 and P-TEFb is required to shield
ESCs from premature differentiation so that sufficient numbers
of cell division can be achieved prior to differentiation tomaintain
proper organismal sizes. Thus, we offer an interesting explana-
tion for PD from the perspective of embryonic stem cells and
link Lin28 to primordial dwarfism etiology.
RESULTS
Regulation of P-TEFb by Larp7 in ESCs
It is generally assumed that loss of Larp7 is associated with
increased cellular growth and proliferation via activation of
P-TEFb, thus being counterintuitive to the global growth failure
phenotype observed in individuals with primordial dwarfism.
Regulation of P-TEFb in ESCs was investigated as most pre-
vious studies were carried out in cancer cells. Knockdown
of Larp7 by small hairpin RNA (shRNA) was utilized to mimic
loss-of-function Larp7 mutants. Two Larp7-specific shRNA
constructs (L7-1 and L7-2) efficiently reduced Larp7 expression
in mouse ESCs (Figure 1A). One construct (L7-1) had higher
knockdown efficiency and was used in experiments that follow
unless specified. After Larp7 knockdown, Cdk9 protein level
(major isoform Cdk942 and minor isoform Cdk955) was not
altered after 3 days (Figure 1B). However, a significant decrease
appeared after 5 days (Figure 1C). The reduction was propor-
tional to the level of Larp7, indicating that Larp7 is required
to maintain P-TEFb levels in cells (Figure 1C). In addition, glyc-
erol gradient analyses demonstrated that Larp7 knockdown
released P-TEFb from 7SK RNP. Transcription inhibitors (DRB
and flavopiridol) and UV irradiation also disrupted the associa-
tion between P-TEFb and 7SK RNP (Figure 1D). However, the
total activity of P-TEFb, reflected by serine 2 phosphorylation
(S2-P) of RNA polymerase II carboxyl terminal domain (CTD),
was similar before and after knockdown of Larp7 for 5 days
(Figure 1E). Lastly, 7SK level was significantly reduced when
Larp7 was knocked down (Figure 1F). Interestingly, Cdk9
mRNA levels remained unchanged after knockdown of Larp7
for 5 days, indicating that downregulation of Cdk9 protein level
may be posttranscriptional (Figure 1G). Together, these results
demonstrated that key aspects of P-TEFb regulation in ESCs is
similar to previous studies carried out in cancer cells.
Under normal conditions, approximately 70% of cellular
P-TEFb is inactive because of sequestration by 7SK RNP. There-
fore, although P-TEFb is freed from 7SK RNP in the absence of
Larp7, a concomitant reduction in its protein level likely offsets
otherwise increased activity (a point we will come back later).
A similar situation is also previously demonstrated in human
cancer cells (He et al., 2008; Krueger et al., 2008). Furthermore,
the expression of many genes remained unchanged in the
absence of Larp7 (see following figures), indicating that the
overall activity of P-TEFb was not upregulated. We concluded
that loss of Larp7 does not cause the same biological effects
as does upregulation of P-TEFb activity.
Larp7 Knockdown Induces the Primed State in ESCs
The biological consequences of Larp7 deficiency were investi-
gated. Under normal conditions, ESCs grow in compact col-
onies. In contrast, flattened cell morphology was prominent
when Larp7 was knocked down. The severity was proportional
to Larp7 dose, strongly indicating that the change in cell
morphology depends on Larp7 (Figure 2A). To rule out potential
artifacts due to unknown factors present in serum, ESCs were
cultured in serum from three different commercial sources.
Similar changes in cell morphology were also observed after
Larp7 knockdown (data not shown). In addition, reduced clono-
genicity was observed during late passages (data not shown).
Flattened cell morphology could be indicative of cellular sen-
esce. However, ESCs with reduced Larp7 had a similar doubling
time and were stained negative for b-galacosidase (data not
shown), a widely accepted marker for senescence (Collado
and Serrano, 2010). Furthermore, fluorescence-activated cell
sorting (FACS) analyses demonstrated a highly similar cell-cycle
distribution regardless of Larp7 status (Figure 2B). Thus, flat-
tened cell morphology induced by Larp7 loss is unlikely caused
by cellular senescence. Lack of cleaved PARP signal also ruled
out apoptosis as the potential explanation for reduced clonoge-
nicity (data not shown).
Upon differentiation, flattened cell morphology is also
commonly observed. To examine this possibility, expression
levels of core pluripotency factors (Young, 2011) were analyzedby protein blot and quantitative PCR (qPCR) (Figures 2C and 2D).
Surprisingly, similar expression levels were observed before and
after knockdown of Larp7, indicating that ESCs are not differen-
tiated. In addition, lineage-affiliated transcripts, representative of
ectoderm (Otx2 and Sox9), mesoderm (T), endoderm (Sox17),
and trophectoderm (Hand1 and Cdx2), were still silenced
(Figure 2E). Furthermore, ESCs could form embryoid bodies
upon differentiation (data not shown). Thus, we concluded that
Larp7 knockdown does not alter pluripotency of ESCs.
Recent studies have demonstrated that mouse ESCs fluctuate
between a naive state (resembling inner cell mass in blastocyst)
and a primed state (a more differentiated state resembling
developmentally more advanced epiblast). Self-renewal and
pluripotency of ESCs in the primed state is still maintained by
the same set of core pluripotency factors as the naive state.
Interestingly, ESCs in this state have low clonogenicity, exhibit
flattened cell morphology, and express lineage-specific tran-
scripts, such as Fgf5 and Blimp1 (Marks et al., 2012; Nichols
and Smith, 2009, 2012).
We therefore examined whether Larp7 knockdown induced
the primed state in ESCs. Indeed, expressions of transcripts
associated with naive state (such as Stella and Nrob1) were
reduced, whereas those associated with the primed state
(such as Fgf5 and Blimp1) were upregulated after Larp7 knock-
down (Figure 2F). To examine whether these ESCs fulfill the
functional criterion of the primed state, that is, prone to differen-
tiation, ESCs were induced to differentiate by leukemia inhibitory
factor (LIF) withdrawal and addition of retinoic acid. Indeed, core
pluripotency factors (Oct4, Nanog, and Rex1) were downregu-
lated at a faster rate when Larp7 was knocked down even at
the earliest differentiation time point (day 1). Reductions in their
mRNA and protein level were accelerated by approximately
1 day (Figures 2G–2I). Accordingly, lineage-specific transcripts
were upregulated with a faster kinetics (Figure 2J). At the first
day of differentiation (day 1), expressions of lineage-specific
transcripts were similar, consistent with the fact that core plurip-
otency network needs to be destructed before initiation of the
differentiation program. Of note, all lineage-specific transcripts
examined were expressed at a highly similar level in the absence
of Larp7 under ESCs culture conditions (day 0), providing
another line of evidence that P-TEFb activity is not upregulated.
Interestingly, many transcripts were induced to express at
a higher level, indicating that freed P-TEFb might be easier
to be recruited to activate expression of these genes during
differentiation.
Taken together, we concluded that Larp7 deficiency induces
the primed state in ESCs based on several observations,
including similar cell-cycle distributions as well as expression
levels of core pluripotency factors, lack of expression of line-
age-specific transcripts (self-renewal and pluripotency is
maintained), flattened cell morphology, induction of primed
state-associated transcripts, and being prone to differentiation
(characteristics of the primed state).
Larp7 Maintains Lin28 Expression in ESCs
Expressions of several transcripts were reduced after Larp7
knockdown. One of them was Lin28 mRNA (Figure 3A). Lin28
has recently emerged as an important positive regulator ofCell Reports 7, 735–746, May 8, 2014 ª2014 The Authors 737
Figure 2. Larp7 Knockdown Primes ESCs for Differentiation
(A) Flattened cell morphology was observed when Larp7 was knocked down. Scale bar, 100 mm.
(B) FACS analyses of ESCs before and after knockdown of Larp7.
(C) Immunoblot analysis of core pluripotency factors before and after knockdown of Larp7 for 5 days.
(D) qPCR analysis of mRNAs of core pluripotency factors after Larp7 was knocked down for 5 days. Data are shown as means ± SE.
(E) Lineage-associated transcripts representative of three germ layers, as well as trophectoderm,were analyzed by RT-PCR before and after knockdown of Larp7
for 5 days.
(F) qPCRanalysis ofmRNAsof genesassociatedwith naiveor primedstate of ESCsbefore andafter knockdownof Larp7 for 5days.Data are shownasmeans±SE.
(G) Immunoblot analysis of core pluripotency factors during the course of ESCs differentiation before and after knockdown of Larp7. Day 0 denotes self-renewal
culture condition. Differentiation was initiated by withdrawal of LIF and addition of RA and maintained for 3 days (day 1, 2, and 3). Representative of three in-
dependent experiments is shown.
(H) Quantification of Oct4 and Nanog expression in immunoblot from (G). Data are shown as means ± SE.
(I) qPCR analysis of Oct4 and Nanog mRNAs during the course of ESCs differentiation with or without knockdown of Larp7. Data are shown as means ± SE.
(J) qPCR analysis of lineage-specific transcripts during the course of ESCs differentiation with or without knockdown of Larp7. Data are shown as means ± SE.mammalian body size (Shinoda et al., 2013; Shyh-Chang and
Daley, 2013; Zhu et al., 2010). Intriguingly, this control by Lin28
is carried out during an early stage of embryogenesis, but not
in neonatal or adult life (Shinoda et al., 2013). Nevertheless,
Lin28 has not been linked to primordial dwarfism etiology.738 Cell Reports 7, 735–746, May 8, 2014 ª2014 The AuthorsThus, we decided to investigate the relationship between
Larp7 and Lin28 further.
We hypothesized that Larp7 is required to maintain Lin28
expression. Consistent with the reduction in its mRNA level,
Lin28 protein level was decreased when Larp7 was knocked
Figure 3. LARP7 Maintains Lin28 Expression in ESCs
(A) qPCR analysis of Lin28 mRNA when Larp7 was knocked down for 3 days.
(B) Immunoblot analysis of Lin28 protein when Larp7 was knocked down for
3 days.
(C) Immunofluorescence analysis of Larp7 and Lin28. Scale bar, 100 mm.
(D) Let-7 reporter assay when Lin28 or Larp7 was knocked down for 3 days.
(E) Immunoblot analysis of Lin28 when Larp7 was knocked down for 2 days by
increasing amounts of shRNA.down by two different shRNA constructs (Figure 3B). Of note,
downregulation of Lin28 preceded reduction of Cdk9. In addition
knockdown of Hexim1 did not reduce Lin28, further suggesting
a P-TEFb-independent mechanism (data not shown). Immuno-
fluorescence studies revealed that Lin28 level was markedly
reduced in Larp7-negative cells (Figure 3C). Furthermore,
Larp7 knockdown also increased let-7 activity to a similar degree
as the direct knockdown of Lin28 (Figure 3D), suggesting that
downregulation of Lin28 by Larp7 deficiency may be biologically
meaningful. Lastly, Lin28 level was reduced in a Larp7 dose-dependent manner (Figure 3E). Taken together, we concluded
that Larp7 maintains the expression of Lin28 in ESCs.
Lin28 Loss Induces the Primed State in ESCs
Lin28 is highly expressed in ESCs and can facilitate reprogram-
ing of somatic cells back to ESCs (Tanabe et al., 2013; Yu et al.,
2007). The best understood function of Lin28 is to block bio-
genesis of let-7 microRNAs (Heo et al., 2008; Rybak et al.,
2008; Viswanathan et al., 2008). However, neither knockdown
of Lin28 nor overexpression of let-7microRNAs leads to differen-
tiation of ESCs (Cho et al., 2012; Melton et al., 2010). Thus, Lin28
is dispensable for self-renewal and pluripotency, and its role in
ESCs awaits elucidation.
We hypothesized that the primed state in ESCs induced by
Larp7 deficiency might be mediated by Lin28 downregulation.
To test this hypothesis, we asked whether knockdown of Lin28
could phenocopy that of Larp7. Consistent with previous reports
(Chang et al., 2012), efficient knockdown of Lin28 did not alter
expressions of core pluripotency factors, indicating that pluri-
potency is maintained (Figures 4A and 4B, upper panel). Similar
to Larp7 knockdown (Figure 2F), transcripts associated with
the primed state were upregulated after Lin28 knockdown
(Figure 4B, lower panel). Flattened cell morphology was also
observed (Figure 4C), similar to Larp7 knockdown (Figure 2A).
Upon differentiation, core pluripotency factors were downregu-
lated at a faster pace, even at the first day of differentiation
(Figure 4D). Accordingly, lineage-specific transcripts were upre-
gulated with a faster kinetics (Figure 4E). Thus, loss of Lin28
recapitulates key aspects of Larp7 deficiency (Figure 2) and
induces the primed state in ESCs.
To examine whether overexpression of Lin28 could rescue
phenotypes caused by loss of Larp7, ESCs were transfected
with Lin28 cDNA in the presence or absence of Larp7-specific
shRNAs (Figure 4F). ESCs still grew in compact colonies in the
presence of ectopically expressed Lin28 (Figure 4G). Although
knockdown of Larp7 induced flattened cell morphology,
compensation by ectopically expressed Lin28 largely rescued
this phenotype (Figure 4G). Importantly, ectopic expression
of Lin28 delayed the onset of differentiation caused by Larp7
deficiency (Figure 4H). Lastly, we examined if Lin28 regulates
P-TEFb. P-TEFb protein level was not altered when Lin28 was
knocked down (Figure 4A). Glycerol gradient analyses further
demonstrated that regulation of P-TEFb was not perturbed
with reduced Lin28 (Figure 4I).
Taken together, these results demonstrate that a Larp7-Lin28
axis safeguards ESCs from precocious differentiation.
Larp7 Interacts with Lin28 mRNA and Maintains
Its Stability
Larp7 is an RNA-binding protein, a constituent binding partner
of 7SK snRNA. It is not known if it can interact with mRNA. Using
an RNA immunoprecipitation (IP) experiment, we investigated
if Larp7 could bind Lin28 mRNA. FLAG-tagged cDNA constructs
were used in order to ensure identical IP conditions and com-
parison of protein amount immunoprecipitated. The identity of
RNA was revealed by RT-PCR. As expected, Larp7, Hexim1,
and Cdk9 efficiently pulled down 7SK snRNA. In contrast, only
Larp7, but neither Hexim1 nor Cdk9, precipitated Lin28 mRNA,Cell Reports 7, 735–746, May 8, 2014 ª2014 The Authors 739
Figure 4. Lin28 Knockdown Phenocopies Larp7 Deficiency
(A) Immunoblot analysis of indicated proteins when Lin28 was knocked down for 3 days in ESCs.
(B) qPCR analysis of mRNAs of core pluripotency factors (upper panel) and transcripts associated with naive and primed states (lower panel) when Lin28 was
knocked down. Data are shown as means ± SE. (C) Flattened cell morphology was observed when Lin28 was knocked down. Scale bar, 100 mm.
(D) qPCR analysis of Oct and Nanog mRNAs during the course of ESCs differentiation with or without knockdown of Lin28. Data are shown as means ± SE.
(E) qPCR analysis of lineage-specific transcripts during the course of ESCs differentiation with or without knockdown of Lin28. Data are shown as means ± SE.
(F) Ectopic expression of Lin28 in the presence of Larp7 shRNA.
(G) Rescue of flattened cell morphology by ectopically expressed Lin28. Scale bar, 100 mm.
(H) Rescue of accelerated differentiation by ectopically expressed Lin28. ESCs were stained for alkaline phosphatase at the first day of differentiation. Positive
staining marks undifferentiated ESCs. Scale bar, 100 mm.
(I) Glycerol gradient analysis of P-TEFb dynamics when Lin28 was knocked down.even when much less Larp7 protein was immunoprecipitated
(Figure 5A, left panel). None of these proteins interacted with
Gapdh or Oct4 mRNA (Figure 5A). Semiquantitative RT-PCR
instead of qPCR was used because the levels of Lin28 mRNA740 Cell Reports 7, 735–746, May 8, 2014 ª2014 The Authors(pulled down by Hexim1 and Cdk9) and Oct4 mRNA (pulled
down by Larp7, Hexim1, and Cdk9) were too low to be
accurately determined by qPCR technique. Interestingly, in the
absence of Larp7, the stability of Lin28 mRNA was markedly
Figure 5. Larp7 Interacts with Lin28 mRNA and Maintains Its
Stability
(A) Larp7 associates with Lin28 mRNA. One-fourth of the immunoprecipitates
was examined by western blot using anti-FLAG antibody (left panel). The rest
were extracted by Trizol to purify associated RNA. Indicated mRNAs were
examined by RT-PCR (right panel). In, input; Vec., plasmid vector control.
(B) Lin28 mRNA stability was reduced in the absence of Larp7. Cells were
treated with flavopiridol to stop RNA Pol II transcription globally. Lin28 mRNA
level was analyzed at the indicated time point by qPCR. Data are shown as
means ± SE.
(C) Nanog mRNA stability was not changed after Larp7 knockdown. Data are
shown as means ± SE.
(D) Immunoblot analysis of indicated proteins when Cdk9 was knocked down
in ESCs for 5 days.decreased (Figure 5B). In contrast, the stability of Nanog and
Oct4 mRNAwas not affected (Figure 5C; data not shown). These
results demonstrate that Larp7 specifically interacts with Lin28
mRNA and maintains its stability in ESCs.
Larp7 knockdown also reduces Cdk9 protein level (Figure 1C).
To examine whether downregulation of Cdk9 affects Lin28
expression, direct knockdown of Cdk9 was carried out in
ESCs. When Cdk9 was knocked down to about 30% (compara-
ble to that when Larp7 was knocked down for 5 days), Lin28 pro-
tein level was not changed (Figure 5D, lane 2). When Cdk9 was
knocked down to a greater degree (Figure 5D, lane 3), a slight
decrease in Lin28 protein level was observed. However, this is
likely caused by differentiation of embryonic stem cells as
demonstrated by a marked downregulation of Oct4. Of note,
when Larp7 was knocked down, the Lin28 protein level was
reduced, whereas the expression of master regulators of embry-
onic stem cell identity, such as Oct4 remained unaltered (Figures
2 and 4). Taken together, these results strongly suggest that
Larp7 directly regulates Lin28 expression.Larp7 Interacts with Star-PAP
We hypothesized that by identification of Larp7-associated pro-
teins, it might provide insight on how Larp7maintains the stability
of Lin28mRNA. Star-PAP was identified as a potential candidate
by mining data from a previous proteomic study using Larp7 as
bait (Krueger et al., 2008). Nevertheless, the interaction between
Larp7 and Star-PAP (denoted as RBM21 in that study) was not
verified. Star-PAP is a novel poly(A) polymerase, recently shown
to regulate stability of several cellular mRNAs (Mellman et al.,
2008).
The interaction between Larp7 and Star-PAP was investi-
gated. As shown in Figure 6A, Star-PAP efficiently pulled down
Larp7, but not Cdk9, whereas Hexim1 could interact with
both, indicating that Star-PAP is not in complex with P-TEFb.
Furthermore, Star-PAP did not interact with 7SK snRNA as
Larp7 and Hexim1 did (Figure 6B). These results demonstrate
that Star-PAP-Larp7 interaction is independent of P-TEFb and
7SK RNP.
Next, we asked if Star-PAP is required to maintain Lin28
expression in ESCs. Knockdown of Star-PAP by three different
shRNA constructs efficiently reduced the mRNA and protein
levels of Lin28 (Figures 6C and 6D). Consistently, downregulation
of Lin28 by Star-PAP knockdown also increased cellular activity
of let-7 microRNAs (Figure 6E). Similar to Larp7 (Figure 5A), Star-
PAP interacted with Lin28 mRNA (Figure 6F). Knockdown of
Larp7 or Star-PAP decreased the level of Lin28 to a similar de-
gree. Of note, double knockdown of Larp7 and Star-PAP only
slightly further decreased the mRNA and protein levels of Lin28
(Figures 6G and 6H), strongly suggesting that Larp7 and Star-
PAP function together tomaintain Lin28 expression. Knockdown
of Star-PAP has recently been shown to cause a poly(A)-tail
defect in selected mRNAs (Mellman et al., 2008). We followed
the procedure used by Mellman et al. (2008) and found that
the percentage of unprocessed Lin28 mRNA was increased
when Star-PAP or Larp7 was knocked down (Figure 6I).
Collectively, these results demonstrate that Larp7 interacts
with Star-PAP to maintain Lin28 expression via regulation of its
mRNA stability.
Interaction Is Compromised between Human Larp7
Mutant Proteins and Star-PAP
Two recent studies identified causative frameshift mutations
in LARP7 in individuals affected by primordial dwarfism and
microcephaly (Alazami et al., 2012; Najmabadi et al., 2011).
The expression of truncated Larp7 protein could not be detected
in cells, likely due to cellular surveillance mechanisms, such as
nonsense-mediated decay, although it is possible that they
may express in cells at an extremely low level. Even expressed,
these mutations would only generate a truncated N-terminal
half of Larp7 protein containing about 300 amino acids, lack of
functional RNA recognition motifs (RRM) (Figure 7A). Therefore,
these mutations are essentially LARP7 null mutations.
We attempted to determine if mutant Larp7 proteins could
interact with Star-PAP. cDNA constructs containing frameshift
mutations were generated in accordance with previously
published studies. As expected, these constructs generated
truncated Larp7 proteins when transfected into cells (Fig-
ure 7B). We also observed that the mutant Larp7 proteins wereCell Reports 7, 735–746, May 8, 2014 ª2014 The Authors 741
Figure 6. Larp7 Interacts with Star-PAP to
Regulate Lin28 mRNA Stability
(A) Star-PAP interacts with Larp7, but not with
P-TEFb. ESCs were transfected with cDNA
encoding FLAG-tagged Star-PAP (F-Star-PAP)
or Hexim1 (Hexim1-F). Immunoprecipitation was
carried out with anti-FLAG antibody, followed by
western blot analyses by anti-Larp7 and Cdk9
antibodies.
(B) Star-PAP does not interact with 7SK snRNA.
ESCs were transfected with cDNA encoding
FLAG-tagged Larp7, Star-PAP, or Hexim1. Im-
munoprecipitates were extracted by Trizol, fol-
lowed by RNA blot analysis.
(C) qPCR analysis of Lin28 mRNA when Star-PAP
was knocked down by three different shRNAs.
(D) Immunoblot analysis of Lin28 protein when
Star-PAP was knocked down.
(E) Let-7 reporter assay when Lin28 or Star-PAP
was knocked down.
(F) Star-PAP interacts with Lin28 mRNA. Experi-
ments were carried out as in Figure 5A.
(G) qPCR analysis of Lin28 mRNA when Larp7 and
Star-PAP were knocked down individually or
simultaneously.
(H) Immunoblot analysis of Lin28 mRNA when
Larp7 and Star-PAP were knocked down individ-
ually or simultaneously. Quantification is shown
below the blot.
(I) qPCR analysis of unprocessed Lin28 mRNA
when Larp7 and Star-PAP were knocked down
individually or simultaneously.expressed at much lower levels compared to that of wild-type
Larp7 under the same conditions (data now shown). The amount
of cDNA transfected was adjusted accordingly so that ex-
pression levels of wild-type and mutant Larp7 proteins were
comparable. Interestingly, Star-PAP could efficiently pull down
wild-type Larp7 protein but pulled down mutant proteins to
a much less efficient extent (Figure 7B), demonstrating that
the interaction is compromised between human Larp7 mutant
proteins and Star-PAP.742 Cell Reports 7, 735–746, May 8, 2014 ª2014 The AuthorsDISCUSSION
In this study, we attempt to offer a poten-
tial mechanism to explain primordial
dwarfism caused by LARP7 deficiency.
We show that ESCs are primed for differ-
entiation in the absence of Larp7 protein.
We further uncover that knockdown of
Larp7 leads to downregulation of Lin28,
a primal positive regulator of organismal
growth. Importantly, similar to Larp7
deficiency, lack of Lin28 also renders
ESCs prone to differentiation, and over-
expression of Lin28 can largely rescue
phenotypes caused by Larp7 loss. Mech-
anistically, we identify an interaction
between Larp7 and a poly(A) polymerase
Star-PAP and further demonstrate thatboth are required to regulate Lin28 expression. It was previously
proposed that defects in PD genes may generate fewer embry-
onic cells during early embryogenesis to account for global
growth failure even in utero (Klingseisen and Jackson, 2011).
Our results are in favor of this hypothesis and provide direct
evidence that the PD gene affects ESCs, cells that generate
all somatic cells. We propose that LARP7 deficiency renders
ESCs prone to differentiation via dysregulation of Lin28 and
P-TEFb. On the one hand, downregulation of Lin28 lowers the
Figure 7. Interaction Is Compromised between Human Larp7
Mutants and Star-PAP
(A) Diagram of human Larp7 protein (wild-type [WT]), and mutants identified
in individuals with primordial dwarfism and microcephaly (343 and 275).
(B) Interaction between Star-PAP and Larp7 proteins. Cells were co-
transfected with cDNA encoding HA-tagged Star-PAP, together with either
FLAG-tagged WT or mutant Larp7 protein. Anti-HA immunoprecipitation
was carried out, followed by western blotting using anti-HA and anti-FLAG
antibodies.threshold for differentiation. On the other hand, freed P-TEFb
may be more easily recruited by master lineage-specific tran-
scription factors, such as MyoD (Giacinti et al., 2006; Simone
and Giordano, 2007) and Gata factors (Bottardi et al., 2011; Ela-
gib et al., 2008; Kaichi et al., 2011; Song et al., 2010; Sunagawa
et al., 2010), to initiate differentiation programs. Overall, fewer
ESCs are generated because of precocious differentiation,
resulting in less somatic cells and therefore smaller organismal
sizes.
Previous biochemical studies have established that Larp7
protein sequesters about 70% of P-TEFb in cells. Thus, it is
generally assumed that without Larp7, P-TEFb is freed and its
overall activity is increased in cells. However, previous studies
and our results here demonstrate that although P-TEFb is freed,
there is a concomitant decrease of P-TEFb protein level to
approximately 30% of normal in various cell types, likely offset-ting otherwise increased P-TEFb activity (He et al., 2008;
Krueger et al., 2008). Consistently, transcription from HIV LTR,
the most sensitive promoter for P-TEFb activity, is only slightly
upregulated in the absence of Larp7 (Krueger et al., 2008). In
this study, most genes express at a similar level when Larp7 is
knocked down. In addition, Larp7 deficiency in zebrafish and
mice does not lead to cell overproliferation but instead leads to
smaller organismal size containing fewer somatic cells (Barboric
et al., 2009; Okamura et al., 2012). Most significantly, Larp7 defi-
ciency results in global growth failure rather than in gigantism in
humans (Alazami et al., 2012). Therefore, Larp7 deficiency does
not generate the same biological outcomes as upregulation of
P-TEFb activity and should not be assumed to be associated
with increased cell growth and proliferation.
We show that Larp7 deficiency in ESCs leads to downregula-
tion of Lin28. Lin28 has recently emerged as an important posi-
tive regulator of mammalian body size (Shinoda et al., 2013;
Shyh-Chang and Daley, 2013; Zhu et al., 2010). Originally identi-
fied as an indispensable regulator of developmental timing in
worms, Lin28 is now known to execute most of its biological
effects via repression of let-7 microRNAs biogenesis as well
as direct regulation of mRNA translation (Cho et al., 2012; Lei
et al., 2012; Shyh-Chang and Daley, 2013; Thornton and Greg-
ory, 2012; Wilbert et al., 2012). Lin28 transgenic mice manifest
increased body size identified in human genetic association
studies (Zhu et al., 2010). During the preparation of this manu-
script, Shinoda et al. (2013) published analyses of the physio-
logic consequences of Lin28 ablation in mice. These knockout
mice exhibit dwarfism during early embryogenesis and in adult-
hood. Intriguingly, conditional knockout experiments revealed
that only embryonic, but neither neonatal nor adult Lin28, defi-
ciency causes dwarfism, demonstrating that Lin28 acts very
early in embryogenesis to regulate organismal size. Lin28 is
highly expressed in ESCs and can facilitate reprograming of
somatic cells back to ESCs. Nevertheless, neither knockdown
of Lin28 nor overexpression of let-7microRNAs leads to differen-
tiation of ESCs. Thus, Lin28 is dispensable for self-renewal and
pluripotency, and its role in ESCs awaits elucidation. Consistent
with previous studies, we find that neither knockdown nor over-
expression of Lin28 affects self-renewal and pluripotency.
Instead, Lin28 deficiency mimics loss of Larp7 and renders
ESCs prone to differentiation. We propose that the main function
of Lin28 in ESCs is to safeguard them from precocious differen-
tiation. Consistent with this notion, recent studies have shown
that Lin28 enhances reprogramming of somatic cells at the
step of ESCs maturation (Tanabe et al., 2013). Originally identi-
fied as a repressor of let-7 microRNA biogenesis, recent studies
have shown that Lin28 directly binds a variety of mRNA and reg-
ulates their translation (Cho et al., 2012; Lei et al., 2012; Wilbert
et al., 2012). It will be of interest to identify the key downstream
effectors of Lin28 that maintain the naive state of ESCs.
Lastly, we identify Star-PAP, a poly(A) polymerase (Li et al.,
2013; Mellman et al., 2008), as a Larp7-interacting protein and
further demonstrate that Star-PAP functions with Larp7 to main-
tain Lin28 expression. Larp7 is a RNA-binding protein and may
recruit Star-PAP to Lin28 mRNA. Consistent with this notion,
human Larp7 mutants do not associate with RNA (data not
shown). Star-PAP was shown to be able to modify a variety ofCell Reports 7, 735–746, May 8, 2014 ª2014 The Authors 743
RNA targets in vitro when purified RNA substrates were used.
However, when cellular extracts were added in the same system,
only selected RNA substrates could be modified (Tazi et al.,
1993; Trippe et al., 1998, 2006). These observations strongly
suggest that there are unknown cellular factors that can modu-
late substrate selectivity of Star-PAP. It is currently under inves-
tigation in our lab whether Larp7 fulfills this function.
In summary, we link Lin28 to primordial dwarfism etiology,
fortifying its role as a primal regulator of organismal size. Mech-
anistically, we undercover that a protein complex containing
Larp7 and Star-PAP is required to maintain Lin28 expression in
ESCs. It will be of great interest to determine whether defects
in other PD genes converge at reducing number of embryonic
stem cells. Understanding the underlying mechanisms will help
us manipulate ESCs in vitro to fulfill its promises in regenerative
medicine.EXPERIMENTAL PROCEDURES
ESC Culture
Feeder-free R1 murine ESCs were cultured in Dulbecco’s modified Eagle’s
medium containing 15% ESC-grade fetal bovine serum (Gemini Bio-Prod-
ucts), supplemented with 103 U/ml LIF (Millipore), 1 mM sodium pyruvate,
100 mM 2-mercaptoethanol, and 100 mM nonessential amino acids (Invitro-
gen). Pluripotency was routinely examined by teratoma formation assay as
previously described (Dai et al., 2012). Alkaline phosphatase staining of cells
was performed following the manufacturer’s instructions (Sigma). To induce
differentiation, LIF was removed and 0.1 mM retinoic acid (Sigma) was added.
Cells were harvested at the indicated time points for the following analyses:
embryoid body formation was carried out as previously described (Dai et al.,
2012). For knockdown experiments, ESCs were transfected with indicated
shRNA constructs by Lipofectamine 2000 (Invitrogen). After 16 hr, ESC culture
was supplemented with 1.5 mg/ml puromycin to remove untransfected cells
until cells were harvested.
Antibodies
Anti-FLAG M2 antibody was purchased from Sigma; anti-RNA Pol II and CTD
Ser-2 phosphorylation was purchased from Covance; anti-HA, Cdk9, and
CylinT1 was purchased from Santa Cruz; anti-Nanog was purchased from
Bethyl; anti-actin was purchased from KangChen; anti-Lin28, Oct4, Gapdh,
and tubulin antibodies were purchased from Zen BioScience; and anti-E-
cadherin was purchased from Abmart. Anti-cyclin K antibody was previously
characterized (Dai et al., 2012). Anti-Larp7 antibody was a gift from Dr. David
Price (University of Iowa). To generate anti-Star-PAP antibody, synthetic
peptide AGEGEQVEVDGWDCSFP (conserved in mice and humans) was
used to immunize rabbits (Zen Bioscience). Crude antiserum was incubated
at 54C for 20 min and passed over the same peptide covalently attached to
Actigel ADL resin (Sterogene) following the manufacturer’s instructions. After
washing with PBS, affinity-purified anti-Star-PAP antibody was eluted with
100 mM glycine (pH 2.5) and neutralized with 1 M Tris base. The antibody
was aliquoted and stored at 80C. The specificity of antibody was determined
by several criteria, including that it recognizes protein of predicted size, it
recognizes protein produced by transfected cDNA encoding Star-PAP, its
signal can be specifically blocked by preincubation with the epitope peptide,
and its signal is diminished by three different shRNAs targeting Star-PAP.
qPCR Analysis
Total RNA was extracted by Trizol (Invitrogen) following the manufacturer’s
instructions, treated with DNase I (Invitrogen), and reverse transcribed by
random hexamers or oligo (dT) using M-MLV Reverse Transcriptase (Invitro-
gen). qPCR was performed by using EvaGreen Supermix (BIO-RAD) on
an Bio-Rad CFX96 Real-Time PCR Detection System (BIO-RAD). Primer
sequences are listed in the Supplemental Experimental Procedures. Expres-744 Cell Reports 7, 735–746, May 8, 2014 ª2014 The Authorssion levels of each gene were normalized to Gapdh mRNA and quantified as
previously described (Peirson et al., 2003).
Immunofluorescence
Cells were grown on six-well tissue-culture plates, fixed for 20 min in 4%
paraformaldehyde/PBS, and washed in PBS twice. Cells were permeabilized
with 0.3% Triton X-100 in PBS for 10 min and then washed in PBS. After
being blocked in 3% BSA in PBS for 1 hr, cells were incubated with anti-
Larp7 (1:200 dilution) or Lin28 (1:200 dilution) antibodies overnight at 4C.
After washing in PBS for 20 min, cells were incubated with Alexa Fluor
488 donkey anti-sheep IgG (H+L) or Alexa Fluor 568 goat anti-mouse IgG
(H+L) secondary antibodies (1:400 dilution) for 1 hr, followed by washing in
PBS for 20 min. To visualize DNA, cells were stained with 0.5 mg/ml of DAPI
after secondary antibody incubation.
FACS Analysis
Cells were fixed with cold ethanol and resuspended in DNA staining solution
(50 mg/ml propidium iodide and 0.1 mg/ml RNase A in PBS) for half an hour.
More than 20,000 events were collected by BD FACSCalibur and analyzed
by MOD Fit software.
Let-7 Reporter Assay
Cells were transfected with indicated shRNA in 12-well plates and reseeded
onto 24-well plates the following day in ESC culture supplemented with
1.5 mg/ml puromycin to remove untransfected cells. After 48 hr, pRL-let 7
reporter (renilla) (Nelson et al., 2004) and PGL2 (firefly) were cotransfected
and luciferase activities were measured 24 hr later using Dual-Luciferase
reporter system (Promega).
Glycerol Gradient Analysis
Glycerol gradient analysis was carried out as previously described (Li et al.,
2007). Briefly, R1 cells were scraped, spun down at 2000 rpm, and then lysed
in buffer A (150 mM NaCl, 2 mM MgCl2, 10 mM HEPES, 1 mM EDTA, 1 mM
DTT, 1% PMSF, EDTA-free protease inhibitor [Roche], and 0.5% Nonidet
P-40) for 10 min on ice. Cell lysates were clarified by centrifugation for
15 min at 13,000 rpm and loaded onto 5%–45% glycerol gradients in buffer
A without Nonidet P-40. Gradients were run at 49,500 rpm for 16 hr in a
Beckman MLS-50 rotor and then fractionated.
RNA Blot Analysis
Northern blot analysis was carried out as previously described (Jeronimo et al.,
2007). Briefly, probes specific for 7SK, U2, and U6 snRNAs were labeled using
T4 PNK (Fermentas). RNA extracted from immunoprecipitates were separated
on 8% denaturing gel and then transferred to a Nytran N+ membrane (GE)
using a semidry blotting apparatus (Bio-Rad). The membrane was fixed by
UV, blocked with ULTRAhyb (Ambion), and then incubated with labeled
probes. The washed membrane was exposed to film (KODAK) at 80C.
The following probes were used.
human 7SK: 50- GGATGGTCGTCCTCTTCGACCGAGCGCGCAGCTTC-30
human U2: 50- GAGCAAGCTCCTATTCCATCTCCCTGCTCCAAAAA-30
mouse 7SK: 50-CGGGGAAGGTCGTCCTCTTC-30
mouse U2: 50-GAGCAAGCTCCTATTCCAACTCCTACTTCCAAAAA-30
U6: 50-AACGCTTCACGAATTTGCGTGTCATCCTTGCGCAG-30
Statistical Analysis
All data were shown asmeans ±SE, derived from at least two biological replica
with at least two technical replica for each experiment. To determine the sig-
nificance between groups, comparisons were made with Student’s t test.
For all statistical tests, the 0.05 confidence level was considered statistically
significant. In all figures, * denotes p value < 0.05 and ** denotes p < 0.01.
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